Debby Bogaert
#146,673
Most Influential Person Now
British physician
Debby Bogaert's AcademicInfluence.com Rankings
Debby Bogaertphilosophy Degrees
Philosophy
#10555
World Rank
#14473
Historical Rank
Logic
#7424
World Rank
#9176
Historical Rank
Download Badge
Philosophy
Debby Bogaert's Degrees
- PhD Medical Sciences King's College London
Why Is Debby Bogaert Influential?
(Suggest an Edit or Addition)According to Wikipedia, Debby Bogaert is a Dutch physician who is Professor of Paediatric Infectious Diseases at the University of Edinburgh. Her research considers the physiology and pathophysiology of respiratory infections.
Debby Bogaert's Published Works
Published Works
- Streptococcus pneumoniae colonisation: the key to pneumococcal disease. (2004) (1775)
- The microbiota of the respiratory tract: gatekeeper to respiratory health (2017) (660)
- Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children (2004) (583)
- Viral and Bacterial Interactions in the Upper Respiratory Tract (2013) (510)
- Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization (2008) (470)
- Mapping the human genetic architecture of COVID-19 (2021) (455)
- Early respiratory microbiota composition determines bacterial succession patterns and respiratory health in children. (2014) (402)
- Variability and Diversity of Nasopharyngeal Microbiota in Children: A Metagenomic Analysis (2011) (398)
- Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study (2003) (324)
- Pneumococcal Capsular Polysaccharide Structure Predicts Serotype Prevalence (2009) (295)
- Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection. (2016) (291)
- Co-infections: potentially lethal and unexplored in COVID-19 (2020) (271)
- Pneumococcal vaccines: an update on current strategies. (2004) (217)
- Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria (2012) (193)
- Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences. A Prospective Cohort Study (2017) (185)
- Scientific consensus on the COVID-19 pandemic: we need to act now (2020) (185)
- The role of the local microbial ecosystem in respiratory health and disease (2015) (184)
- The impact of breastfeeding on nasopharyngeal microbial communities in infants. (2014) (175)
- Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life (2019) (170)
- Development of Upper Respiratory Tract Microbiota in Infancy is Affected by Mode of Delivery (2016) (165)
- Deep Sequencing Analyses of Low Density Microbial Communities: Working at the Boundary of Accurate Microbiota Detection (2012) (152)
- Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. (2009) (149)
- Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients (2015) (138)
- Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study (2021) (136)
- Pneumococcal Carriage in Children in The Netherlands: a Molecular Epidemiological Study (2001) (121)
- Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis (2012) (114)
- Immunosenescence and pneumococcal disease: an imbalance in host-pathogen interactions. (2014) (113)
- Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis. (2016) (109)
- Inflammation induced by influenza virus impairs human innate immune control of pneumococcus (2018) (104)
- Bacterial and viral respiratory tract microbiota and host characteristics in children with lower respiratory tract infections: a matched case-control study (2019) (103)
- Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study (2021) (98)
- Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK (2021) (94)
- Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children (2014) (94)
- Streptococcus pneumoniae in Saliva of Dutch Primary School Children (2014) (85)
- Effect of Seven-Valent Pneumococcal Conjugate Vaccine on Staphylococcus aureus Colonisation in a Randomised Controlled Trial (2011) (84)
- Superiority of Trans-Oral over Trans-Nasal Sampling in Detecting Streptococcus pneumoniae Colonization in Adults (2013) (83)
- Impaired Innate and Adaptive Immunity to Streptococcus pneumoniae and Its Effect on Colonization in an Infant Mouse Model (2009) (77)
- Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study (2021) (77)
- Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the pneumococcal conjugate vaccine in the Netherlands. (2016) (76)
- Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. (2010) (73)
- Carriage of Streptococcus pneumoniae in Aged Adults with Influenza-Like-Illness (2015) (68)
- Amplicon based MinION sequencing of SARS-CoV-2 and metagenomic characterisation of nasopharyngeal swabs from patients with COVID-19 (2020) (63)
- Detection of neutralising antibodies to SARS-CoV-2 to determine population exposure in Scottish blood donors between March and May 2020 (2020) (60)
- Impaired Innate Mucosal Immunity in Aged Mice Permits Prolonged Streptococcus pneumoniae Colonization (2013) (58)
- Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media. (2004) (58)
- Host-Pathogen Interaction during Pneumococcal Infection in Patients with Chronic Obstructive Pulmonary Disease (2004) (58)
- Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media. (2004) (58)
- The respiratory microbiome and respiratory infections. (2017) (58)
- Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK (2021) (56)
- Concordance between upper and lower airway microbiota in infants with cystic fibrosis (2017) (51)
- COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study (2021) (49)
- Impact of early daycare on healthcare resource use related to upper respiratory tract infections during childhood: prospective WHISTLER cohort study (2014) (49)
- From doctors as patients: a manifesto for tackling persisting symptoms of covid-19 (2020) (48)
- Molecular surveillance of nasopharyngeal carriage of Streptococcus pneumoniae in children vaccinated with conjugated polysaccharide pneumococcal vaccines (2016) (47)
- Epidemiology of nasopharyngeal carriage of Neisseria meningitidis in healthy Dutch children. (2005) (47)
- Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine (2019) (47)
- Nasopharyngeal Colonization Elicits Antibody Responses to Staphylococcal and Pneumococcal Proteins That Are Not Associated with a Reduced Risk of Subsequent Carriage (2012) (45)
- Loss of Microbial Topography between Oral and Nasopharyngeal Microbiota and Development of Respiratory Infections Early in Life. (2019) (44)
- Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study (2021) (42)
- The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model. (2010) (41)
- Multiplex PCR reveals a high rate of nasopharyngeal pneumococcal 7-valent conjugate vaccine serotypes co-colonizing indigenous Warao children in Venezuela. (2009) (40)
- Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial (2022) (39)
- Nasopharyngeal co-colonization with Staphylococcus aureus and Streptococcus pneumoniae in children is bacterial genotype independent. (2007) (39)
- Early Life Microbiota and Respiratory Tract Infections. (2020) (37)
- Microbial Dysbiosis in Common Variable Immune Deficiencies: Evidence, Causes, and Consequences. (2017) (37)
- Multiplex opsonophagocytosis assay (MOPA): a useful tool for the monitoring of the 7-valent pneumococcal conjugate vaccine. (2004) (36)
- Dynamics of pneumococcal colonization in healthy Dutch children. (2006) (36)
- Acute Otorrhea in Children with Tympanostomy Tubes: Prevalence of Bacteria and Viruses in the Post-Pneumococcal Conjugate Vaccine Era (2015) (35)
- Pneumococcal carriage among indigenous Warao children in Venezuela: serotypes, susceptibility patterns, and molecular epidemiology. (2007) (34)
- Molecular Epidemiology of Pneumococcal Colonization in Response to Pneumococcal Conjugate Vaccination in Children with Recurrent Acute Otitis Media (2005) (34)
- Increased risk of pneumonia in residents living near poultry farms: does the upper respiratory tract microbiota play a role? (2017) (33)
- Evaluation of Concordance Between the Microorganisms Detected in the Nasopharynx and Middle Ear of Children With Otitis Media (2013) (32)
- The human microbiome and juvenile idiopathic arthritis (2016) (32)
- Low prevalence of recently discovered pneumococcal serotype 6C isolates among healthy Dutch children in the pre-vaccination era. (2008) (31)
- Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease. (2007) (31)
- Serotype Distribution and Antibiotic Susceptibility of Streptococcus pneumoniae Strains Carried by Children Infected with Human Immunodeficiency Virus (2014) (30)
- The respiratory microbiota during health and disease: a paediatric perspective (2015) (29)
- Rectal swabs are a reliable proxy for faecal samples in infant gut microbiota research based on 16S-rRNA sequencing (2019) (29)
- Respiratory Microbiota Dynamics following Streptococcus pneumoniae Acquisition in Young and Elderly Mice (2014) (28)
- Multivariate Approach for Studying Interactions between Environmental Variables and Microbial Communities (2012) (28)
- Genetic Relatedness between Pneumococcal Populations Originating from the Nasopharynx, Adenoid, and Tympanic Cavity of Children with Otitis Media (2005) (26)
- Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment. (2020) (25)
- Two Randomized Trials of the Effect of Live Attenuated Influenza Vaccine on Pneumococcal Colonization (2019) (23)
- Molecular Epidemiology of Pneumococcal Carriage among Children with Upper Respiratory Tract Infections in Hanoi, Vietnam (2002) (23)
- Colony blot assay: a useful method to detect multiple pneumococcal serotypes within clinical specimens. (2004) (22)
- The UK needs a sustainable strategy for COVID-19 (2020) (22)
- Genetic Relatedness within Serotypes of Penicillin-Susceptible Streptococcus pneumoniaeIsolates (2000) (21)
- Impact of preterm birth on brain development and long-term outcome: protocol for a cohort study in Scotland (2020) (21)
- Carriage and invasive isolates of Streptococcus pneumoniae in Caracas, Venezuela: the relative invasiveness of serotypes and vaccine coverage (2011) (20)
- Characterising the respiratory microbiome (2019) (19)
- Molecular Epidemiology of Penicillin-NonsusceptibleStreptococcus pneumoniae among Children in Greece (2000) (19)
- Respiratory Microbiota Predicts Clinical Disease Course of Acute Otorrhea in Children With Tympanostomy Tubes. (2019) (19)
- Salivary Immune Responses to the 7-Valent Pneumococcal Conjugate Vaccine in the First 2 Years of Life (2012) (18)
- Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae. (2011) (17)
- Development of antibodies against the putative proteinase maturation protein A in relation to pneumococcal carriage and otitis media. (2006) (17)
- The value of open-source clinical science in pandemic response: lessons from ISARIC (2021) (17)
- Lack of Interference between Streptococcus pneumoniae and Staphylococcus aureus in HIV-infected individuals? (2006) (16)
- Alternative Sampling Methods for Detecting Bacterial Pathogens in Children with Upper Respiratory Tract Infections (2012) (15)
- Infant respiratory syncytial virus prophylaxis and nasopharyngeal microbiota until 6 years of life: a subanalysis of the MAKI randomised controlled trial. (2020) (15)
- Does pneumococcal conjugate vaccine influence Staphylococcus aureus carriage in children? (2008) (15)
- Exploring Immune Development in Infants With Moderate to Severe Atopic Dermatitis (2018) (15)
- The porcine respiratory microbiome: recent insights and future challenges (2021) (15)
- Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England (2021) (14)
- Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool. (2015) (14)
- Development of the respiratory tract microbiota in cystic fibrosis (2016) (14)
- Author Correction: Impact of delivery mode-associated gut microbiota dynamics on health in the first year of life (2019) (13)
- Emergence of rifampin-resistant Streptococcus pneumoniae as a result of antimicrobial therapy for penicillin-resistant strains. (2001) (13)
- Prevalence and Clinical Course in Invasive Infections with Meningococcal Endotoxin Variants (2012) (12)
- The Role of B Cells in Carriage and Clearance of Mycoplasma pneumoniae From the Respiratory Tract of Mice (2018) (12)
- Nasopharyngeal Microbiota Profiles in Rural Venezuelan Children Are Associated With Respiratory and Gastrointestinal Infections (2020) (12)
- Molecular characteristics of penicillin-binding protein genes of penicillin-nonsusceptible Streptococcus pneumoniae isolated in the Netherlands. (2001) (12)
- Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine (2021) (11)
- Dried Saliva Spots: A Robust Method for Detecting Streptococcus pneumoniae Carriage by PCR (2016) (10)
- Niche- and Gender-Dependent Immune Reactions in Relation to the Microbiota Profile in Pediatric Patients with Otitis Media with Effusion (2020) (10)
- Molecular Epidemiology of Penicillin-Susceptible Non-β-Lactam-Resistant Streptococcus pneumoniae Isolates from Greek Children (2003) (10)
- Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study (2022) (10)
- A systematic review of microbial markers for risk prediction of colorectal neoplasia (2022) (10)
- Unraveling the Molecular Mechanisms Underlying the Nasopharyngeal Bacterial Community Structure (2016) (10)
- Immunogenicity of a 7-valent pneumococcal conjugate vaccine (PCV7) and impact on carriage in Venezuelan children at risk of invasive pneumococcal diseases. (2014) (10)
- Early-life viral infections are associated with disadvantageous immune and microbiota profiles and recurrent respiratory infections (2022) (10)
- Benchmarking laboratory processes to characterise low-biomass respiratory microbiota (2021) (9)
- Effect of Live Attenuated Influenza Vaccine on Pneumococcal Carriage (2018) (8)
- General factors of white matter microstructure from DTI and NODDI in the developing brain (2021) (8)
- Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media. (2005) (8)
- Severity of Respiratory Infections With Seasonal Coronavirus Is Associated With Viral and Bacterial Coinfections (2020) (8)
- Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus (2021) (8)
- Molecular Epidemiology of Penicillin-Susceptible, Multidrug-Resistant Serotype 6B Pneumococci Isolated from Children in Greece (2001) (7)
- Distinct clinical symptom patterns in patients hospitalised with COVID-19 in an analysis of 59,011 patients in the ISARIC-4C study (2022) (7)
- RESPIRE: The National Institute for Health Research's (NIHR) Global Respiratory Health Unit (2018) (7)
- Individual and Group Response of Treatment with Ivacaftor on Airway and Gut Microbiota in People with CF and a S1251N Mutation (2021) (7)
- Therapeutic Targeting of the Respiratory Microbiome. (2022) (6)
- Decreased production of epithelial-derived antimicrobial molecules at mucosal barriers during early life (2021) (6)
- Pneumococcal colonization impairs nasal and lung mucosal immune responses to Live Attenuated Influenza Vaccination in adults (2020) (6)
- 100 years of influenza research seen through the lens of Covid-19 (2020) (5)
- Gut microbiota–derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis (2022) (5)
- Immunoglobulin A deficiency in children, an undervalued clinical issue. (2019) (5)
- The respiratory microbiota during and following mechanical ventilation for respiratory infections in children (2020) (5)
- Correction: Long-Term Effects of Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis (2012) (5)
- Microbial community networks across body sites are associated with susceptibility to respiratory infections in infants (2021) (5)
- Presumed Risk Factors and Biomarkers for Severe Respiratory Syncytial Virus Disease and Related Sequelae: Protocol for an Observational Multicenter, Case-Control Study From the Respiratory Syncytial Virus Consortium in Europe (RESCEU). (2020) (5)
- Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population (2016) (4)
- Covid-19: an open letter to the UK?s chief medical officers (2020) (4)
- Mother-to-infant microbiota transmission and infant microbiota development across multiple body sites. (2023) (4)
- Antibiotic treatment and stewardship in the era of microbiota-oriented diagnostics (2018) (4)
- Effect of conjugate pneumococcal vaccine on recurrent acute otitis media (2003) (3)
- Development of the respiratory tract microbiota in cystic fibrosis. (2016) (2)
- The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24–59 months in The Gambia: a phase 4, open label, randomised, controlled trial (2021) (2)
- Microbiome-gut-brain axis in brain development, cognition and behavior during infancy and early childhood (2022) (2)
- Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children (2021) (2)
- Resilience of the nasopharyngeal microbiota following childhood lower respiratory tract infection (2019) (2)
- Microbial and clinical factors are related to recurrence of symptoms after childhood lower respiratory tract infection (2021) (2)
- The earliy-life microbiome: the key to respiratory health? (2019) (2)
- Bacterial DNA in Fetal Lung Samples May Be Explained by Sample Contamination (2020) (2)
- Inflammation induced by influenza virus impairs innate control of human pneumococcal carriage (2018) (1)
- Symptom‐based case definitions for COVID‐19: Time and geographical variations for detection at hospital admission among 260,000 patients (2022) (1)
- The oropharyngeal microbiome of COPD patients and controls in a livestock dense area (2021) (1)
- Air pollution from livestock farms and the oropharyngeal microbiome of COPD patients and controls. (2022) (1)
- Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study (2022) (1)
- WS07.5 Gut microbiome in healthy children and children with cystic fibrosis during the first 18 months of life (2016) (1)
- Infant RSV prophylaxis, RSV infection, and nasopharyngeal microbiota at age six years (2019) (1)
- Maturation of microbial networks across body sites is associated with susceptibility to childhood respiratory infections (2019) (1)
- 81 The concordance between the microbiome of the upper and lower respiratory tract is investigated in infants with cystic fibrosis (2015) (1)
- DYNAMIC DEVELOPMENT OF THE GUT MICROBIOTA IN CHILDREN WITH CYSTIC FIBROSIS AND HEALTHY CHILDREN DURING THE FIRST 18 MONTHS OF LIFE (2017) (0)
- 79 Development of the upper respiratory tract microbiome was investigated longitudinally in cystic fibrosis infants and controls 0–6 months of age (2015) (0)
- Prior upregulation of interferon pathways in the nasopharynx impacts viral shedding following live attenuated influenza vaccine challenge in children (2021) (0)
- Impact of nutritional supplementation on prolonged symptoms and the respiratory microbiome in children with acute respiratory infection (2020) (0)
- The Effect of Live Attenuated Influenza Vaccine on Pneumococcal Colonisation Densities Among Children Aged 24-59 Months in the Gambia - A Phase IV, Open Label, Randomised Controlled Trial (2021) (0)
- The porcine respiratory microbiome: recent insights and future challenges (2021) (0)
- Topical or oral antibiotics for children with acute otitis media presenting with ear discharge: study protocol of a randomised controlled non-inferiority trial (2021) (0)
- CD81 as a novel target to suppress leukocyte transmigration (2004) (0)
- Pneumococcal colonization and carriage (2014) (0)
- Effects of early-life antibiotics on the developing infant gut microbiome and resistome: a randomized trial (2022) (0)
- Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine (2019) (0)
- ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19 (2022) (0)
- Asymptomatic Viral Presence in Early Life Precedes Recurrence of Respiratory Tract Infections (2022) (0)
- The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection (2023) (0)
- Bacterial and fungal communities in tracheal aspirates of intubated COVID-19 patients: a pilot study (2022) (0)
- The microbiota in respiratory tract infections: from association to intervention (2022) (0)
- Title : Nasopharyngeal microbiota , host transcriptome and disease severity in children with respiratory syncytial virus infection (2016) (0)
- Developmentofantibodiesagainsttheputativeproteinase maturation proteinA in relation topneumococcal carriage andotitismedia (2006) (0)
- Streptococcus pyogenes colonization in children aged 24-59 months in The Gambia: Impact of Live Attenuated Influenza Vaccine and associated serological responses (2022) (0)
- WS1.3 Respiratory microbiota dynamics in newborns with cystic fibrosis and healthy controls: A longitudinal study (2013) (0)
- Host-pathogen interaction during Streptococcus pneumoniae colonization and infection (2004) (0)
- University of Groningen Effect of seven-valent pneumococcal conjugate vaccine on staphylococcus aureus colonisation in a randomised controlled trial (2011) (0)
- Inflammation induced by influenza virus impairs human innate immune control of pneumococcus (2018) (0)
- Chronic Obstructive Pulmonary Disease Pneumococcal Infection in Patients with Host-Pathogen Interaction during (2017) (0)
- Late Breaking Abstract - Microbiota and lower respiratory tract infections in children: a matched case-control study (2017) (0)
- Higher off-target amplicon detection rate in MiSeq v3 compared to v2 reagent kits in the context of 16S-rRNA-sequencing (2022) (0)
- A Battle of Wills: Antibiotics and Bacteria Lock Horns in a Struggle for Survival (1997) (0)
- Microbiota development in early life mediates association between mode of delivery and vaccine responses (2021) (0)
- Effect of intra-partum azithromycin on the development of the infant nasopharyngeal microbiota: A post hoc analysis of a double-blind randomized trial (2022) (0)
- Study protocol for a randomised controlled trial evaluating the clinical effect of antibiotic prophylaxis in children with recurrent respiratory tract infections: the Approach study (2021) (0)
- Colonisation par S. aureus et S. pneumoniae (2004) (0)
- Antigen presentation. How sweet (2010) (0)
- A novel method to standardise serum IgA measurements shows an increased prevalence of IgA deficiency in young children with recurrent respiratory tract infections (2021) (0)
- Salivary antibody responses to ten-valent pneumococcal conjugate vaccination following two different immunization schedules in a healthy birth cohort (2021) (0)
- Symptomatology during seasonal coronavirus infections in children is associated with viral and bacterial co-detection (2020) (0)
- Mode of delivery modulates the intestinal microbiota and impacts the response to vaccination (2022) (0)
This paper list is powered by the following services:
Other Resources About Debby Bogaert
What Schools Are Affiliated With Debby Bogaert?
Debby Bogaert is affiliated with the following schools: